The FDA has approved a new presentation of Alvotech and Teva’s SELARSDI, for the...
This NMA serves to bridge the gap between trials for both therapies and compare ...
Servier Canada has announced Health Canada's approval of VORANIGO for Grade 2 ID...
A year after the first samRNA vaccine approval, experts say others are likely to...
The companies have presented positive Phase II data during an oral session at ID...
The UK’s National Institute of Health and Care Excellence (NICE) said the drug p...
In an exclusive interview, the CEO of ImmunoPrecise Antibodies described the ben...
FibroBiologics has entered a master services agreement with Charles River Labora...
A partial hold was placed on the trial after results showed variance between squ...
Astellas Pharma has received approval from the FDA for VYLOY in conjunction with...
GSK has announced a £50m ($54.3m) investment in a partnership with the Universit...
As a companion diagnostic, Oncomine will be used to identify patients eligible f...
This trial investigated the potential of Nanoscope Therapeutics' MCO-010 to rest...
A stake by France-owned Bpifrance and promise of local job retention have allaye...
Arcutis Canada, has received Health Canada's approval for ZORYVE to treat seborr...
The funding will support Seaport’s technology platform, which helps drugs be abs...
